8. Predatory pricing practices by companies have seen them purchase long-used drugs and then rapidly increase the price. They keep out competition by eliminating limiting access to data to make substitutes. This has brought regulatory change at the state level. Some states are capping prices, whereas others are establishing drug affordability boards or requiring justification before any drug price can be raised more than 20%.